+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Epinephrine Autoinjector Market 2020-2024 - Product Image

Global Epinephrine Autoinjector Market 2020-2024

  • ID: 5019098
  • Report
  • April 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ALK-Abello AS
  • kaleo Inc.
  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • MORE
Global Epinephrine Autoinjector Market 2020-2024

The epinephrine autoinjector market is poised to grow by $ 762.51 mn during 2020-2024 progressing at a CAGR of 7% during the forecast period. The report on the epinephrine autoinjector market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies, technological advances and marketing strategies. In addition, increasing prevalence of allergies is anticipated to boost the growth of the market as well.

The epinephrine autoinjector market analysis include end-user segment and geographic landscapes.

The epinephrine autoinjector market is segmented as below:

By End-user
  • Hospitals
  • Clinics
  • Individuals
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the tentative product launches as one of the prime reasons driving the epinephrine autoinjector market growth during the next few years. Also, growing awareness about epinephrine autoinjectors and patient assistance programs will lead to sizable demand in the market.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The epinephrine autoinjector market covers the following areas:
  • Epinephrine autoinjector market sizing
  • Epinephrine autoinjector market forecast
  • Epinephrine autoinjector market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epinephrine autoinjector market vendors that include Adamis Pharmaceuticals Corp., ALK-Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., kaleo Inc., Lincoln Medical Ltd., Mylan NV, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.. Also, the epinephrine autoinjector market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALK-Abello AS
  • kaleo Inc.
  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Dosage
  • Market segments
  • Comparison by Dosage
  • 0. 30gm - Market size and forecast 2019-2024
  • 0. 15gm - Market size and forecast 2019-2024
  • 0. 50gm - Market size and forecast 2019-2024
  • Market opportunity by Dosage
Market Segmentation by Age Group
  • Market segmentation by Age Group
Market Segmentation by End-user
  • Hospitals and clinics
  • Individuals
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - demand-led growth
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Adamis Pharmaceuticals Corp.
  • ALK-Abello AS
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • kaleo Inc.
  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Other1 - Market share 2019-2024 (%)
22: Comparison by Other1
23: 0. 30gm - Market size and forecast 2019-2024 ($ million)
24: 0. 30gm - Year-over-year growth 2019-2024 (%)
25: 0. 15gm - Market size and forecast 2019-2024 ($ million)
26: 0. 15gm - Year-over-year growth 2019-2024 (%)
27: 0. 50gm - Market size and forecast 2019-2024 ($ million)
28: 0. 50gm - Year-over-year growth 2019-2024 (%)
29: Market opportunity by Other1
30: Customer landscape
31: Market share by geography 2019-2024 (%)
32: Geographic comparison
33: North America - Market size and forecast 2019-2024 ($ million)
34: North America - Year-over-year growth 2019-2024 (%)
35: Europe - Market size and forecast 2019-2024 ($ million)
36: Europe - Year-over-year growth 2019-2024 (%)
37: Asia - Market size and forecast 2019-2024 ($ million)
38: Asia - Year-over-year growth 2019-2024 (%)
39: ROW - Market size and forecast 2019-2024 ($ million)
40: ROW - Year-over-year growth 2019-2024 (%)
41: Key leading countries
42: Market opportunity by geography ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Adamis Pharmaceuticals Corp. - Overview
50: Adamis Pharmaceuticals Corp. - Product and service
51: Adamis Pharmaceuticals Corp. - Key offerings
52: Adamis Pharmaceuticals Corp. - Key customers
53: Adamis Pharmaceuticals Corp. - Segment focus
54: ALK-Abello AS - Overview
55: ALK-Abello AS - Product and service
56: ALK-Abello AS - Key offerings
57: ALK-Abello AS - Key customers
58: ALK-Abello AS - Segment focus
59: Amneal Pharmaceuticals Inc. - Overview
60: Amneal Pharmaceuticals Inc. - Business segments
61: Amneal Pharmaceuticals Inc. - Key offerings
62: Amneal Pharmaceuticals Inc. - Key customers
63: Amneal Pharmaceuticals Inc. - Segment focus
64: Bausch Health Companies Inc. - Overview
65: Bausch Health Companies Inc. - Business segments
66: Bausch Health Companies Inc. - Key offerings
67: Bausch Health Companies Inc. - Key customers
68: Bausch Health Companies Inc. - Segment focus
69: kaleo Inc. - Overview
70: kaleo Inc. - Product and service
71: kaleo Inc. - Key offerings
72: kaleo Inc. - Key customers
73: kaleo Inc. - Segment focus
74: Lincoln Medical Ltd. - Overview
75: Lincoln Medical Ltd. - Product and service
76: Lincoln Medical Ltd. - Key offerings
77: Lincoln Medical Ltd. - Key customers
78: Lincoln Medical Ltd. - Segment focus
79: Mylan NV - Overview
80: Mylan NV - Business segments
81: Mylan NV - Key offerings
82: Mylan NV - Key customers
83: Mylan NV - Segment focus
84: Novartis AG - Overview
85: Novartis AG - Business segments
86: Novartis AG - Key offerings
87: Novartis AG - Key customers
88: Novartis AG - Segment focus
89: Pfizer Inc. - Overview
90: Pfizer Inc. - Business segments
91: Pfizer Inc. - Key offerings
92: Pfizer Inc. - Key customers
93: Pfizer Inc. - Segment focus
94: Teva Pharmaceutical Industries Ltd. - Overview
95: Teva Pharmaceutical Industries Ltd. - Business segments
96: Teva Pharmaceutical Industries Ltd. - Key offerings
97: Teva Pharmaceutical Industries Ltd. - Key customers
98: Teva Pharmaceutical Industries Ltd. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • ALK-Abello AS
  • kaleo Inc.
  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • MORE
The research recognizes the following companies as the key players in the global epinephrine autoinjector market: Adamis Pharmaceuticals Corp., ALK-Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., kaleo Inc., Lincoln Medical Ltd., Mylan NV, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the tentative product launches."

According to the report, one of the major drivers for this market is the increasing prevalence of allergies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Adamis Pharmaceuticals Corp.
  • ALK-Abello AS
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • kaleo Inc.
  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll